Contrast-Enhanced Ultrasound of the Carotid Artery in Patients With Large Vessel Vasculitis: Correlation With Positron Emission Tomography Findings

Arthritis Care and Research

Volumn 69, Issue 1, 2017, Pages 143-149

  Germanò, Giuseppe ^a   Macchioni, Pierluigi ^a   Possemato, Niccolò ^a   Boiardi, Luigi ^a   Nicolini, Alberto ^a   Casali, Massimiliano ^a   Versari, Annibale ^a   Pipitone, Nicolò ^a   Salvarani, Carlo ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AORTA ARCH SYNDROME; ARTICLE; CAROTID ARTERY; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLOR DOPPLER FLOWMETRY; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG UPTAKE; ECHOGRAPHY; FEMALE; GIANT CELL ARTERITIS; HUMAN; INTERMETHOD COMPARISON; MALE; POSITRON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SUPERIOR CAVA VEIN; VASCULARIZATION; VASCULITIS; CAROTID ARTERY DISEASE; DIAGNOSTIC IMAGING; MIDDLE AGED; PROCEDURES;

ADULT; CAROTID ARTERY DISEASES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; ULTRASONOGRAPHY; VASCULITIS;

EID: 85003597919     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22906     Document Type: Article

References (36)

1. Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev 2011;11:61–7.
2. Miller DV, Maleszewski JJ. The pathology of large-vessel vasculitides. Clin Exp Rheumatol 2011;29:S92–8.
3. Cavazza A, Muratore F, Boiardi L, Restuccia G, Pipitone N, Pazzola G, et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol 2014;38:1360–70.
4. Pipitone N, Versari A, Hunder GG, Salvarani C. Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am 2013;39:593–608.
5. Prieto-González S, Arguis P, Cid MC. Imaging in systemic vasculitis. Curr Opin Rheumatol 2015;27:53–62.
6. Magnoni M, Dagna L, Coli S, Cianflone D, Sabbadini MG, Maseri A. Assessment of Takayasu arteritis activity by carotid contrast-enhanced ultrasound. Circ Cardiovasc Imaging 2011;4:e1–2.
7. Giordana P, Baqué-Juston MC, Jeandel PY, Mondot L, Hirlemann J, Padovani B, et al. Contrast-enhanced ultrasound of carotid artery wall in Takayasu disease: first evidence of application in diagnosis and monitoring of response to treatment. Circulation 2011;124:245–7.
8. Possemato N, Macchioni P, Germanò G, Pipitone N, Versari A, Salvarani C. Clinical images: PET-CT and contrast-enhanced ultrasound in Takayasu's arteritis. Rheumatology (Oxford) 2014;53:447.
9. Schinkel AF, van den Oord SC, van der Steen AF, van Laar JA, Sijbrands EJ. Utility of contrast-enhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis. Eur Heart J Cardiovasc Imaging 2014;15:541–6.
10. Magnoni M, Coli S, Marrocco-Trischitta MM, Melisurgo G, De Dominicis D, Cianflone D, et al. Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries. Eur J Echocardiogr 2009;10:260–4.
11. Staub D, Schinkel AF, Coll B, Coli S, van der Steen AF, Reed JD, et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010;3:761–71.
12. Partovi S, Loebe M, Aschwanden M, Baldi T, Jager KA, Feinstein SB, et al. Contrast-enhanced ultrasound for assessing carotid atherosclerotic plaque lesions. Am J Roentgenol 2012;198:W13–9.
13. Hoogi A, Adam D, Hoffman A, Kerner H, Reisner S, Gaitini D. Carotid plaque vulnerability: quantification of neovascularization on contrast-enhanced ultrasound with histopathologic correlation. Am J Roentgenol 2011;196:431–6.
14. Staub D, Partovi S, Schinkel AF, Coll B, Uthoff H, Aschwanden M, et al. Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US. Radiology 2011;258:618–26.
15. Feinstein SB. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol 2006;48:236–43.
16. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994;120:919–29.
17. Drielsma RF, Burnett JR, Gray-Weale AC, Byrne K, Lusby RJ. Carotid artery disease: the influence of diabetes mellitus. J Cardiovasc Surg (Torino) 1988;29:692–6.
18. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis: Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003;229:340–6.
19. Thapar A, Shalhoub J, Averkiou M, Mannaris C, Davies AH, Leen EL. Dose-dependent artifact in the far wall of the carotid artery at dynamic contrast-enhanced US. Radiology 2012;262:672–9.
20. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991;44:763–70.
21. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129–34.
22. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122–8.
23. Miller DV, Maleszewski JJ. The pathology of large-vessel vasculitides. Clin Exp Rheumatol 2011;29 Suppl 64:S92–8.
24. Cid MC, Cebrián M, Font C, Coll-Vinent B, Hernández-Rodríguez J, Esparza J, et al. Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions. Arthritis Rheum 2000;43:184–94.
25. Hernández-Rodríguez J, Segarra M, Vilardell C, Sánchez M, García-Martínez A, Esteban MJ, et al. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 2003;107:2428–34.
26. Ten Kate GL, van den Oord SC, Sijbrands EJ, van der Lugt A, de Jong N, Bosch JG, et al. Current status and future developments of contrast-enhanced ultrasound of carotid atherosclerosis. J Vasc Surg 2013;57:539–46.
27. Arnaud L, Haroche J, Malek Z, Archambaud F, Gambotti L, Grimon G, et al. Is (18) F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 2009;60:1193–200.
28. Besson FL, Parienti JJ, Bienvenu B, Prior JO, Costo S, Bouvard G, et al. Diagnostic performance of F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011;38:1764–72.
29. Lee KH, Cho A, Choi YJ, Lee SW, Ha YJ, Jung SJ, et al. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis. Arthritis Rheum 2012;64:866–75.
30. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012;39:344–53.
31. Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J, et al. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 2012,5:422–9.
32. Prieto-González S, Depetris M, García-Martínez A, Espigol-Frigolé G, Tavera-Bahillo I, Corbera-Bellata M, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. Ann Rheum Dis 2014;73:1388–92.
33. Hjelmgren O, Johansson L, Prahl U, Schmidt C, Fredé-Lindqvist J, Bergström GM. A study of plaque vascularization and inflammation using quantitative contrast-enhanced US and PET/CT. Eur J Radiol 2014;83:1184–9.
34. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818–24.
35. Menezes LJ, Kotze CW, Agu O, Richards T, Brookes J, Goh VJ, et al. Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation. J Nucl Med 2011;52:1698–703.
36. Folco EJ, Sheikine Y, Rocha VZ, Christen T, Shvartz E, Sukhova GK, et al. Hypoxia but not inflammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol 2011;58:603–14.